Antibodies against YKL-40 and uses thereof
US12428495B2 · kind B2 · utility
0Cited by
2References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 28, 2023 |
| Grant date | Sep 30, 2025 |
| Priority date | — |
| Expiry date | Apr 28, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/569
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to antibodies capable of binding murine and/or human YKL-40, as well as to compositions comprising one or more such antibodies. The invention also relates to such antibodies for use in a method of treatment of various diseases, such as cancer alone or in combination with other anti-cancer agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.